Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

VSEE vs WELL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VSEE
VSee Health, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$3M
5Y Perf.-98.0%
WELL
Welltower Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$149.25B
5Y Perf.+104.3%

VSEE vs WELL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VSEE logoVSEE
WELL logoWELL
IndustryMedical - Healthcare Information ServicesREIT - Healthcare Facilities
Market Cap$3M$149.25B
Revenue (TTM)$15M$11.63B
Net Income (TTM)$-12M$1.43B
Gross Margin54.6%39.1%
Operating Margin-69.3%4.4%
Forward P/E78.4x
Total Debt$10M$21.38B
Cash & Equiv.$326K$5.03B

VSEE vs WELLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VSEE
WELL
StockJun 24May 26Return
VSee Health, Inc. (VSEE)1002.0-98.0%
Welltower Inc. (WELL)100204.3+104.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: VSEE vs WELL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: WELL leads in 5 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. VSee Health, Inc. is the stronger pick specifically for growth and revenue expansion. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
VSEE
VSee Health, Inc.
The Growth Play

VSEE is the clearest fit if your priority is growth exposure.

  • Rev growth 80.7%, EPS growth -13.9%, 3Y rev CAGR 12.4%
  • 80.7% revenue growth vs WELL's 35.8%
Best for: growth exposure
WELL
Welltower Inc.
The Real Estate Income Play

WELL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 2 yrs, beta 0.13, yield 1.3%
  • 223.1% 10Y total return vs VSEE's -99.0%
  • Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthVSEE logoVSEE80.7% revenue growth vs WELL's 35.8%
Quality / MarginsWELL logoWELL12.3% margin vs VSEE's -85.8%
Stability / SafetyWELL logoWELLBeta 0.13 vs VSEE's 1.40
DividendsWELL logoWELL1.3% yield; 2-year raise streak; the other pay no meaningful dividend
Momentum (1Y)WELL logoWELL+42.7% vs VSEE's -85.9%
Efficiency (ROA)WELL logoWELL2.3% ROA vs VSEE's -66.7%, ROIC 0.5% vs -17.5%

VSEE vs WELL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

VSEEVSee Health, Inc.
FY 2024
Subscription and Circulation
56.4%$4M
Technology Service
27.1%$2M
Health Care, Patient Service
16.5%$1M
WELLWelltower Inc.
FY 2025
Senior Housing - Operating
81.1%$8.5B
Triple Net
11.4%$1.2B
Outpatient Medical
7.5%$782M

VSEE vs WELL — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLWELLLAGGINGVSEE

Income & Cash Flow (Last 12 Months)

WELL leads this category, winning 4 of 6 comparable metrics.

WELL is the larger business by revenue, generating $11.6B annually — 799.3x VSEE's $15M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to VSEE's -85.8%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVSEE logoVSEEVSee Health, Inc.WELL logoWELLWelltower Inc.
RevenueTrailing 12 months$15M$11.6B
EBITDAEarnings before interest/tax-$7M$2.8B
Net IncomeAfter-tax profit-$12M$1.4B
Free Cash FlowCash after capex-$5M$2.5B
Gross MarginGross profit ÷ Revenue+54.6%+39.1%
Operating MarginEBIT ÷ Revenue-69.3%+4.4%
Net MarginNet income ÷ Revenue-85.8%+12.3%
FCF MarginFCF ÷ Revenue-31.1%+21.9%
Rev. Growth (YoY)Latest quarter vs prior year+18.7%+40.3%
EPS Growth (YoY)Latest quarter vs prior year+99.5%+22.5%
WELL leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

VSEE leads this category, winning 2 of 2 comparable metrics.
MetricVSEE logoVSEEVSee Health, Inc.WELL logoWELLWelltower Inc.
Market CapShares × price$3M$149.2B
Enterprise ValueMkt cap + debt − cash$12M$165.6B
Trailing P/EPrice ÷ TTM EPS-0.03x153.25x
Forward P/EPrice ÷ next-FY EPS est.78.42x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple66.40x
Price / SalesMarket cap ÷ Revenue0.28x13.99x
Price / BookPrice ÷ Book value/share3.35x
Price / FCFMarket cap ÷ FCF52.41x
VSEE leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

WELL leads this category, winning 5 of 7 comparable metrics.

On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs VSEE's 4/9, reflecting strong financial health.

MetricVSEE logoVSEEVSee Health, Inc.WELL logoWELLWelltower Inc.
ROE (TTM)Return on equity+3.5%
ROA (TTM)Return on assets-66.7%+2.3%
ROICReturn on invested capital-17.5%+0.5%
ROCEReturn on capital employed-63.3%+0.6%
Piotroski ScoreFundamental quality 0–947
Debt / EquityFinancial leverage0.49x
Net DebtTotal debt minus cash$9M$16.3B
Cash & Equiv.Liquid assets$326,115$5.0B
Total DebtShort + long-term debt$10M$21.4B
Interest CoverageEBIT ÷ Interest expense-4.76x0.26x
WELL leads this category, winning 5 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

WELL leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $100 for VSEE. Over the past 12 months, WELL leads with a +42.7% total return vs VSEE's -85.9%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs VSEE's -78.5% — a key indicator of consistent wealth creation.

MetricVSEE logoVSEEVSee Health, Inc.WELL logoWELLWelltower Inc.
YTD ReturnYear-to-date-59.0%+14.3%
1-Year ReturnPast 12 months-85.9%+42.7%
3-Year ReturnCumulative with dividends-99.0%+189.5%
5-Year ReturnCumulative with dividends-99.0%+202.3%
10-Year ReturnCumulative with dividends-99.0%+223.1%
CAGR (3Y)Annualised 3-year return-78.5%+42.5%
WELL leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

WELL leads this category, winning 2 of 2 comparable metrics.

WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than VSEE's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 97.0% from its 52-week high vs VSEE's 6.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVSEE logoVSEEVSee Health, Inc.WELL logoWELLWelltower Inc.
Beta (5Y)Sensitivity to S&P 5001.40x0.13x
52-Week HighHighest price in past year$2.52$219.59
52-Week LowLowest price in past year$0.17$142.65
% of 52W HighCurrent price vs 52-week peak+6.9%+97.0%
RSI (14)Momentum oscillator 0–10027.760.2
Avg Volume (50D)Average daily shares traded560K2.6M
WELL leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

WELL is the only dividend payer here at 1.30% yield — a key consideration for income-focused portfolios.

MetricVSEE logoVSEEVSee Health, Inc.WELL logoWELLWelltower Inc.
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$226.50
# AnalystsCovering analysts34
Dividend YieldAnnual dividend ÷ price+1.3%
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS$2.76
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

WELL leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). VSEE leads in 1 (Valuation Metrics).

Best OverallWelltower Inc. (WELL)Leads 4 of 6 categories
Loading custom metrics...

VSEE vs WELL: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is VSEE or WELL a better buy right now?

For growth investors, VSee Health, Inc.

(VSEE) is the stronger pick with 80. 7% revenue growth year-over-year, versus 35. 8% for Welltower Inc. (WELL). Welltower Inc. (WELL) offers the better valuation at 153. 3x trailing P/E (78. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — VSEE or WELL?

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to -99. 0% for VSee Health, Inc. (VSEE). Over 10 years, the gap is even starker: WELL returned +223. 1% versus VSEE's -99. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — VSEE or WELL?

By beta (market sensitivity over 5 years), Welltower Inc.

(WELL) is the lower-risk stock at 0. 13β versus VSee Health, Inc. 's 1. 40β — meaning VSEE is approximately 951% more volatile than WELL relative to the S&P 500.

04

Which is growing faster — VSEE or WELL?

By revenue growth (latest reported year), VSee Health, Inc.

(VSEE) is pulling ahead at 80. 7% versus 35. 8% for Welltower Inc. (WELL). On earnings-per-share growth, the picture is similar: Welltower Inc. grew EPS -11. 5% year-over-year, compared to -1386. 8% for VSee Health, Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — VSEE or WELL?

Welltower Inc.

(WELL) is the more profitable company, earning 8. 8% net margin versus -553. 7% for VSee Health, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 3. 3% versus -596. 4% for VSEE. At the gross margin level — before operating expenses — VSEE leads at 68. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — VSEE or WELL?

In this comparison, WELL (1.

3% yield) pays a dividend. VSEE does not pay a meaningful dividend and should not be held primarily for income.

07

Is VSEE or WELL better for a retirement portfolio?

For long-horizon retirement investors, Welltower Inc.

(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). Both have compounded well over 10 years (WELL: +223. 1%, VSEE: -99. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between VSEE and WELL?

These companies operate in different sectors (VSEE (Healthcare) and WELL (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

WELL pays a dividend while VSEE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

VSEE

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 32%
Run This Screen
Stocks Like

WELL

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform VSEE and WELL on the metrics below

Revenue Growth>
%
(VSEE: 18.7% · WELL: 40.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.